Host Inflammatory Cytokine Gene Expression (IL-4, IL-13)

Host inflammatory cytokine gene expression, specifically focusing on IL-4 and IL-13, refers to the transcriptional activation and regulation of genes encoding these cytokines. These cytokines, produced predominantly by Th2 cells and other immune and non-immune cells, are key mediators of allergic inflammation, immune modulation, and tissue remodeling. They signal through receptor complexes involving IL-4Rα and activate downstream signaling pathways, primarily the JAK-STAT6 pathway. Dysregulation of IL-4 and IL-13 expression contributes to various pathological conditions, including allergic diseases, autoimmune disorders, and fibrosis. Targeting these pathways is a therapeutic strategy for treating severe allergic and inflammatory disorders.

Other names

IL-4 Gene ExpressionIL-13 Gene ExpressionInterleukin-4 Gene ExpressionInterleukin-13 Gene ExpressionTh2 Cytokine Gene Expression

Drugs targeting IL-4 and IL-13 pathways typically block cytokine binding to receptors or inhibit downstream signaling (e.g., JAK-STAT pathway) to reduce inflammatory responses.